The annual World Vaccine Congress Europe is back for its 19th year in Portugal’s lovely capital Lisbon from October 29-31!
Terrapinn, the event’s sponsor, has partnered with Labiotech to provide our awesome readers with a FREE TICKET to the event. Attending the conference will put you at the forefront of the vaccines industry and no matter where your interest lies, there is content, networking and partnering opportunities tailored to your needs.
Continue reading to learn more about the event and how to win.
There are so many reasons to attend. These are our top three:
- Hear from and interact with over 170 senior speakers from leading government and non-profit organizations, including Jim O’Neil (University of Manchester), Ana Maria Henao-Restrepo (WHO), Emily Erbelding (NIH), Dr Melanie Saville (CEPI), Dr Thomas G. Evans (Vaccitech), Dr Wayne Koff (Human Vaccines Project), Ruxandra Draghia-Akli (MSD), Professor Helen McShane (Oxford University) and others.
- Understand how to prepare for outbreaks and develop vaccines for neglected diseases from influenza, RSV, MERS-CoV, Lassa fever, Nipah, Zika and other arboviruses.
- If you are interested in immunotherapy vaccines, CAR T-cells, oncolytic viruses, dendritic cells, checkpoint inhibitors, or combinational methods, look no further – there is an agenda packed with immuno-oncology sessions at the co-located Immuno-Oncology Profiling World Congress.
These are just a few of the reasons we think you would enjoy the event. Download the brochure for the full low-down.
Past Attendee’s Thoughts
David Hipkiss, CEO of French biotech Enesi Pharma described the event as “the perfect launch vehicle for Enesi Pharma and [it] surpassed all our expectations.”
Brigitte Lamontagne, Business Development of Switzerland’s Société Générale de Surveillance described the event as: “If someone is interested in novel vaccine development approaches, this is definitely a great event for both scientists and business staff.”
And Sander Verkerk, Marketing Manager and Communications of Rotterdamn-based Viroclinics Bioscience thought that the conference was a “well balanced mix between academic content and business content. High quality business contacts.”
How to win?
Fill out the form – it only takes 1 minute!
Images via Terrapinn, Shutterstock.com
Let's Continue The Conversation
Feel free to send us comments about this article to firstname.lastname@example.org and/or comment on that article on social media.